Atrial Fibrillation and Chronic Kidney Disease: Aetiology and Management

Area of Science:

• Nephrology
• Cardiology
• Electrophysiology

Background:

• Chronic kidney disease (CKD) and atrial fibrillation (AF) are independently linked to increased cardiovascular risks.
• Growing evidence indicates a higher prevalence and incidence of AF in patients with CKD.
• The interplay between CKD and AF contributes significantly to morbidity and mortality.

Purpose of the Study:

• To offer a comprehensive review of current management strategies for treating AF in patients with concurrent CKD.
• To explore the potential electrophysiological mechanisms linking AF and CKD.
• To present current evidence on pharmacological and procedural interventions for AF in CKD.

Main Methods:

• Literature review of current evidence and studies.
• Exploration of electrophysiological mechanisms.
• Analysis of pharmacological rate and rhythm control strategies.
• Review of procedural interventions for AF in CKD patients.

Main Results:

• The management of concomitant AF and CKD presents unique complexities.
• Electrophysiological mechanisms linking AF and CKD require further investigation.
• Current evidence supports various pharmacological and procedural approaches, though optimal strategies are still evolving.

Conclusions:

• Treating AF in the context of CKD requires careful consideration of disease interactions.
• Understanding the cyclical relationship between CKD and AF progression is crucial for effective management.
• Integrated management strategies are essential for improving outcomes in patients with both conditions.